Browse by author
Lookup NU author(s): Professor Alison Yarnall, Dr Deborah Mayne, Dr Terry AsprayORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The prevalence of type 2 diabetes increases with age and is set to increase further over the next 20 years. Despite a quarter of diabetic patients being over the age of 75 years, there is a paucity of trial data in older patients. In this article we review drug and insulin treatments, old and new, presenting recent trial evidence, particularly related to thiazolidinediones and the newest anti-diabetic drugs: the incretins. We also discuss the challenge of current guidelines, which recommend strict control of glucose, lipids, and blood pressure, which must be balanced against risks of polypharmacy, drug side-effects and impairments both cognitive and physical. Diabetic emergencies are also discussed in this review, including the diagnosis and management of hyperglycaemic hyperosmolar state, ketosis and hypoglycaemia. This article finishes with a section on diabetic complications and their treatment. © 2008 Rila Publications Ltd.
Author(s): Yarnall A, Mayne D, Aspray T
Publication type: Review
Publication status: Published
Journal: CME Geriatric Medicine
Year: 2008
Volume: 10
Issue: 1
Pages: 20-34
Print publication date: 01/01/2008
ISSN (print): 1475-1453
ISSN (electronic):
